A method to visualize the uncertainty of the prediction of radiobiological models

Physica Medica

Volumn 29, Issue 5, 2013, Pages 556-561

  Zhang, Lanlan ^a   Hub, Martina ^a   Thieke, Christian ^a,b   Floca, Ralf O ^a   Karger, Christian P ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Inter individual radio sensitivity variation; Normal tissue complication probability (NTCP); Tumor control probability (TCP); Uncertainty

Indexed keywords

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; DOSIMETRY; HISTOGRAM; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PLEURA MESOTHELIOMA; PREDICTION; RADIATION DOSE; RADIATION PNEUMONIA; RADIOBIOLOGY; RADIOSENSITIVITY; UNCERTAINTY;

INTER-INDIVIDUAL RADIO-SENSITIVITY VARIATION; NORMAL TISSUE COMPLICATION PROBABILITY (NTCP); TUMOR CONTROL PROBABILITY (TCP); UNCERTAINTY;

MODELS, STATISTICAL; NEOPLASMS; ORGANS AT RISK; RADIATION INJURIES; RADIOBIOLOGY; SOFTWARE; TREATMENT OUTCOME; UNCERTAINTY;

EID: 84881662880     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2012.11.004     Document Type: Article

References (35)

1. Fowler J.F. The linear-quadratic formula and progress in fractionated radiotherapy. The British Journal of Radiology 1989, 62:679-694.
2. Nahum A.E., Sanchez-Nieto B. Tumour control probability modelling: Basic principles and applications in treatment planning. Physica Medica 2001, 17:13-23.
3. Lyman J.T. Normal tissue complication probabilities - variable dose per fraction. International Journal of Radiation Oncology, Biology, Physics 1992, 22:247-250.
4. Kutcher G.J., Burman C., Brewster L., Goitein M., Mohan R. Histogram reduction method for calculating complication probabilities for 3-dimensional treatment planning evaluations. International Journal of Radiation Oncology, Biology, Physics 1991, 21:137-146.
5. Roberts S.A., Hendry J.H. Arealistic closed-form radiobiological model of clinical tumor-control data incorporating intertumor heterogeneity. International Journal of Radiation Oncology, Biology, Physics 1998, 41:689-699.
6. Carlone M.C., Warkentin B., Stavrev P., Fallone B.G. Fundamental form of a population TCP model in the limit of large heterogeneity. Medical Physics 2006, 33:1634-1642.
7. Sanchez-Nieto B., Nahum A.E. Bioplan: software for the biological evaluation of. Radiotherapy treatment plans. Medical Dosimetry: Official Journal of the American Association of Medical Dosimetrists 2000, 25:71-76.
8. El Naqa I., Suneja G., Lindsay P.E., Hope A.J., Alaly J.R., Vicic M., et al. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships. Physics in Medicine and Biology 2006, 51:5719-5735.
9. Zhao B., Joiner M.C., Orton C.G., Burmeister J. "SABER": a new software tool for radiotherapy treatment plan evaluation. Medical Physics 2010, 37:5586-5592.
10. Warkentin B., Stavrev P., Stavreva N., Field C., Fallone B.G. ATCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets. Journal of Applied Clinical Medical Physics/American College of Medical Physics 2004, 5:50-63.
11. Gayou O., Parda D.S., Miften M. EUCLID: an outcome analysis tool for high-dimensional clinical studies. Physics in Medicine and Biology 2007, 52:1705-1719.
12. Burman C., Kutcher G.J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. International Journal of Radiation Oncology, Biology, Physics 1991, 21:123-135.
13. Hakkinen A.M., Laasonen A., Linnainmaa K., Mattson K., Pyrhonen S. Radiosensitivity of mesothelioma cell lines. Acta Oncol 1996, 35:451-456.
14. Deacon J., Peckham M.J., Steel G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 1984, 2:317-323.
15. Zagars G.K., Schultheiss T.E., Peters L.J. Inter-tumor heterogeneity and radiation dose-control curves. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 1987, 8:353-361.
16. Boyer A.L., Schultheiss T. Effects of dosimetric and clinical uncertainty on complication-free local tumor-control. Radiotherapy and Oncology 1988, 11:65-71.
17. Sanchez-Nieto B., Nahum A.E. The delta-TCP concept: a clinically useful measure of tumor control probability. International Journal of Radiation Oncology, Biology, Physics 1999, 44:369-380.
18. Webb S., Nahum A.E. Amodel for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Physics in Medicine and Biology 1993, 38:653-666.
19. Seppenwoolde Y., Lebesque J.V. Partial irradiation of the lung. Seminars in Radiation Oncology 2001, 11:247-258.
20. Sanchez-Nieto B., Nahum A.E., Dearnaley D.P. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data. International Journal of Radiation Oncology, Biology, Physics 2001, 49:487-499.
21. Deasy J.O., Chao K.S.C., Markman J. Uncertainties in model-based outcome predictions for treatment planning. International Journal of Radiation Oncology, Biology, Physics 2001, 51:1389-1399.
22. Schilstra C., Meertens H. Calculation of the uncertainty in complication probability for various dose-response models, applied to the parotid gland. International Journal of Radiation Oncology, Biology, Physics 2001, 50:147-158.
23. Rutkowska E., Baker C., Eswar C., Fenwick J., Littler J., Malik Z., et al. Confidence intervals on NTCP estimates for individualised dose-prescription. Radiation Oncology 2008, 89:29.
24. Dasu A., Toma-Dasu I., Fowler J.F. Should single or distributed parameters be used to explain the steepness of tumour control probability curves?. Physics in Medicine and Biology 2003, 48:387-397.
25. Niemierko A. Ageneralized concept of equivalent uniform dose (EUD). Medical Physics 1999, 26:1100.
26. Pelin-Enlund K., Husgafvel-Pursiainen K., Tammilehto L., Klockars M., Jantunen K., Gerwin B.I., et al. Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell lines from five patients. Carcinogenesis 1990, 11:673-681.
27. McAleer M.F., Tsao A.S., Liao Z. Radiotherapy in malignant pleural mesothelioma. International Journal of Radiation Oncology, Biology, Physics 2009, 75:326-337.
28. Kwa S.L., Lebesque J.V., Theuws J.C., Marks L.B., Munley M.T., Bentel G., et al. Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. International Journal of Radiation Oncology, Biology, Physics 1998, 42:1-9.
29. Svolos P., Tsougos I., Kyrgias G., Kappas C., Theodorou K. On the use of published radiobiological parameters and the evaluation of NTCP models regarding lung pneumonitis in clinical breast radiotherapy. Australasian Physical & Engineering Sciences in Medicine/supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine 2011, 34:69-81.
30. Allen A.M., Czerminska M., Janne P.A., Sugarbaker D.J., Bueno R., Harris J.R., et al. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. International Journal of Radiation Oncology, Biology, Physics 2006, 65:640-645.
31. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. International Journal of Radiation Oncology, Biology, Physics 1991, 21:109-122.
32. Ljungkvist A.S., Bussink J., Kaanders J.H., Wiedenmann N.E., Vlasman R., van der Kogel A.J. Dynamics of hypoxia, proliferation and apoptosis after irradiation in a murine tumor model. Radiation Research 2006, 165:326-336.
33. Overgaard J., Bartelink H. Introduction: towards predicting outcome of radiotherapy - at last. Seminars in Radiation Oncology 2012, 22:87-90.
34. Mackay R.I., Hendry J.H. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 1999, 50:67-75.
35. Niemierko A., Goitein M. Modeling of normal tissue response to radiation: the critical volume model. International Journal of Radiation Oncology, Biology, Physics 1993, 25:135-145.